Thermo Fisher Scientific TMO Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Consolidated revenues by Business | ||||||
| Analytical Instruments | $7.55B+0.8% | $7.55B+1.2% | $7.53B+2.9% | $7.44B+2.5% | $7.49B+3.7% | |
| Laboratory Products and Biopharma Services | $24.38B— | $23.98B— | $23.54B— | $23.31B— | —— | |
| Life Sciences Solutions | $10.67B+10.1% | $10.37B+7.7% | $10.03B+5.6% | $9.83B+3.0% | $9.69B+0.4% | |
| Specialty Diagnostics | $4.67B+2.6% | $4.68B+3.6% | $4.61B+3.4% | $4.57B+3.5% | $4.55B+3.3% | |
| Cost of revenues by Business | ||||||
| Analytical Instruments | $3.89B— | $3.85B— | $3.72B— | $3.62B— | —— | |
| Laboratory Products and Biopharma Services | $18.96B— | $18.61B— | $18.26B— | $18.12B— | —— | |
| Life Sciences Solutions | $4.08B— | $3.93B— | $3.72B— | $3.66B— | —— | |
| Specialty Diagnostics | $2.7B— | $2.72B— | $2.69B— | $2.67B— | —— | |
| Operating Income (Loss) by Business | ||||||
| Analytical Instruments | $1.69B-13.5% | $1.74B-11.2% | $1.82B-3.1% | $1.84B-2.8% | $1.96B+3.6% | |
| Laboratory Products and Biopharma Services | $3.4B— | $3.35B— | $3.25B— | $3.16B— | —— | |
| Life Sciences Solutions | $3.89B+11.2% | $3.77B+7.6% | $3.67B+6.6% | $3.55B+2.3% | $3.5B+2.1% | |
| Specialty Diagnostics | $1.27B+8.2% | $1.26B+8.4% | $1.21B+4.8% | $1.18B+3.2% | $1.17B+2.7% | |
| Other segment items by Business | ||||||
| Analytical Instruments | $152M— | $151M— | $161M— | $157M— | —— | |
| Laboratory Products and Biopharma Services | -$429M— | -$422M— | -$385M— | -$394M— | —— | |
| Life Sciences Solutions | $218M— | $213M— | $218M— | $184M— | —— | |
| Specialty Diagnostics | -$181M— | -$183M— | -$169M— | -$177M— | —— | |
| Selling, general and administrative expenses by Business | ||||||
| Analytical Instruments | $1.24B— | $1.24B— | $1.26B— | $1.26B— | —— | |
| Laboratory Products and Biopharma Services | $2.4B— | $2.39B— | $2.36B— | $2.37B— | —— | |
| Life Sciences Solutions | $1.94B— | $1.91B— | $1.87B— | $1.87B— | —— | |
| Specialty Diagnostics | $714M— | $708M— | $708M— | $711M— | —— | |
| Research and development expenses by Business | ||||||
| Analytical Instruments | $575M— | $573M— | $572M— | $562M— | —— | |
| Laboratory Products and Biopharma Services | $58M— | $56M— | $57M— | $59M— | —— | |
| Life Sciences Solutions | $545M— | $553M— | $556M— | $561M— | —— | |
| Specialty Diagnostics | $177M— | $178M— | $182M— | $184M— | —— | |
| Purchases of property, plant and equipment by Business | ||||||
| Analytical Instruments | $116M— | $124M— | $106M— | $107M— | —— | |
| Laboratory Products and Biopharma Services | $1.06B— | $1.01B— | $1.04B— | $921M— | —— | |
| Life Sciences Solutions | $129M— | $152M— | $146M— | $141M— | —— | |
| Specialty Diagnostics | $130M— | $128M— | $138M— | $130M— | —— | |
| Depreciation of property, plant and equipment by Business | ||||||
| Analytical Instruments | $106M— | $104M— | $103M— | $102M— | —— | |
| Laboratory Products and Biopharma Services | $618M— | $604M— | $626M— | $690M— | —— | |
| Life Sciences Solutions | $262M— | $251M— | $236M— | $232M— | —— | |
| Specialty Diagnostics | $93M— | $91M— | $100M— | $106M— | —— | |
| Consolidated revenues by Product | ||||||
| Consumables | $19.03B+8.1% | $18.66B+6.1% | $18.16B+4.1% | $17.86B+2.9% | $17.61B+1.1% | |
| Instruments | $7.23B-2.9% | $7.3B-1.9% | $7.33B+1.3% | $7.29B-0.7% | $7.45B+0.9% | |
| Service revenues | $18.94B+6.1% | $18.59B+4.2% | $18.25B+3.1% | $18.07B+2.3% | $17.84B+0.8% | |
| Consolidated revenues by Geography | ||||||
| Asia-Pacific | $8.18B+2.4% | $8.1B+1.8% | $8.03B+2.5% | $7.94B+1.5% | $7.99B+3.1% | |
| Europe | $12.16B+11.9% | $11.83B+8.9% | $11.35B+5.0% | $11.03B+2.4% | $10.86B+1.0% | |
| North America | $23.23B+3.2% | $23.03B+2.4% | $22.79B+2.5% | $22.69B+1.7% | $22.5B0.0% | |
| Other regions | $1.63B+5.2% | $1.6B+2.3% | $1.57B+5.7% | $1.56B+7.9% | $1.55B+4.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Thermo Fisher Scientific break its business down?
- Thermo Fisher Scientific (TMO) reports consolidated revenues by business across 4 parts — Analytical Instruments, Laboratory Products and Biopharma Services, Life Sciences Solutions and Specialty Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Thermo Fisher Scientific's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Thermo Fisher Scientific's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
